A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer

NCT01269216 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: 5-FU with leucovorin
DRUG: TS-1 with Irinotecan

Sponsor

Yonsei University